Cas:2754-18-9 [3-(hydroxymethyl)oxetan-3-yl]methanol manufacturer & supplier

Chemical Name:[3-(hydroxymethyl)oxetan-3-yl]methanol

CAS.NO:2754-18-9

Synonyms:3,3-Oxetanedimethanol;(3-hydroxymethyl-oxetan-3-yl)-methanol;oxetane-3,3-diyldimethanol;[(hydroxymethyl)oxetan-3-yl]methanol;2,2-bis(hydroxymethyl)oxetane;F2147-0750;3,3-Bis-hydroxymethyl-oxetan;3,3-bis(hydroxymethyl)oxetane;Oxetane,3,3-bis-(hydroxymethyl)

Molecular Formula:C₅H₁₀O₃

Molecular Weight:118.13100

HS Code:2932999099

Physical and Chemical Properties:

Melting point:N/A

Boiling point:237.7ºC at 760 mmHg

Density:1.21 g/cm3

Index of Refraction:

PSA:49.69000

Exact Mass:118.06300

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3,3-Oxetanedimethanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Oxetane,3,3-bis-(hydroxymethyl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,3-bis(hydroxymethyl)oxetane Use and application,3,3-bis(hydroxymethyl)oxetane technical grade,usp/ep/jp grade.

Related News: According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter. [3-(hydroxymethyl)oxetan-3-yl]methanol manufacturer Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm. [3-(hydroxymethyl)oxetan-3-yl]methanol supplier The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route. [3-(hydroxymethyl)oxetan-3-yl]methanol vendor China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. [3-(hydroxymethyl)oxetan-3-yl]methanol factory Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.